Health: New Skin Saver

Despite all the exhortations to stay out of the sun, a million Americans will develop skin cancer this year. The only good news for die-hard sun worshippers is that treatments are improving. The FDA just gave 3M Pharmaceuticals the go-ahead to market Aldara as a therapy for a common type of basal-cell carcinoma (BCC)--the first new topical approved for BCC in 25 years. In trials, cancerous lesions cleared up after three months for more than 80% of patients.

A new medication helps, but it's no reason to throw common sun-sense to the wind. Aldara does not treat superficial BCC tumors larger...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!